The FDA has issued recent safety communications about compounded versions of popular GLP-1 drugs such as semaglutide and tirzepatide, warning of dosing errors, ingredient differences, and potential contamination. Here’s what patients and families should understand about the risks, legal limits, and how to protect themselves.
The American Diabetes Association’s 2026 Standards of Care update national guidance on glucose monitoring, medications, heart and kidney protection, and mental health screening. Here’s what changed — and what it means for patients across the United States.
As spring and summer approach, federal health agencies are reminding Americans that skin cancer is largely preventable. Here’s what the CDC, FDA, USPSTF, and National Cancer Institute say about UV exposure, sunscreen safety, and who should take extra precautions.
The Indian Health Service plans to phase out mercury-containing dental amalgam fillings in its facilities by 2027. Here’s what federal agencies say about safety, who may be at higher risk, and whether patients need to remove existing fillings.
Anti-amyloid antibody treatments such as lecanemab are now part of Alzheimer’s care in the United States—but only for certain patients. Here’s who qualifies, what Medicare covers, how MRI safety monitoring works, and what families should realistically expect.
Federal breach data show ransomware continues to disrupt U.S. hospitals, affecting patient care and exposing medical records. Here’s what that means for your health, privacy, and what you can do if your data are compromised.
If you’re 50 to 80 and have a significant smoking history, you may qualify for annual low-dose CT lung cancer screening. Here’s what the evidence shows, who is eligible, what the trade-offs are, and how insurance coverage works in 2026.
A major Cochrane review finds that spinal manipulation offers modest relief for chronic low back pain—about similar to exercise and other recommended non-drug treatments. Here’s what that means for patients, safety, Medicare coverage, and when to seek urgent care.
Colorectal cancer screening now starts at age 45 for most adults. Here’s what current U.S. guidelines say, how stool tests compare with colonoscopy, what happens after a positive result, and what insurance and Medicare typically cover.
FDA-approved anti-amyloid drugs like lecanemab can modestly slow early Alzheimer’s disease—but they are not cures. Here’s who qualifies, what the clinical trials showed, the real risks, and how Medicare coverage works in 2026.
Most women 65 and older should be screened for osteoporosis, even if they feel fine. Here’s what the current U.S. Preventive Services Task Force recommendation says, what a DXA scan measures, and how insurance coverage works.
The U.S. Preventive Services Task Force has updated its guidance on screening for iron deficiency anemia. Here’s what the new grades mean for infants, pregnant people, and adults—and how they affect preventive care coverage under federal law.
Blood in the urine—whether you can see it or not—should never be ignored. Here’s what hematuria can mean, when it may signal bladder cancer, how doctors evaluate it, and when to seek urgent care.
If you have asthma, federal health officials consider you at higher risk for complications from flu and COVID-19, and some groups face higher RSV risk. Here’s what the 2025–2026 respiratory virus season means for vaccines, action plans, and when to seek care.
Medicare Advantage plans and other insurers increasingly use algorithms to review prior authorization and claims. Federal watchdog findings and new CMS rules clarify what’s allowed, what isn’t, and what rights patients have when care is denied.
AI tools are increasingly used in U.S. hospitals and clinics, but not all of them are regulated the same way. Here’s how the FDA oversees AI-enabled medical devices, what clearance really means, and what patients should ask when AI is involved in their care.
A surge of FDA-approved biosimilars for adalimumab and a redesigned Medicare Part D benefit with a $2,000 annual out-of-pocket cap are reshaping how Americans with arthritis pay for biologic drugs in 2026. Here’s what that means for your costs, coverage, and care decisions.
Spring allergy season is underway across the United States, and federal data show pollen seasons—especially ragweed—are starting earlier and lasting longer in many regions. Here’s what the evidence says, who is most at risk, and how to protect yourself and your family.
Federal minimum staffing standards for nursing homes are now phasing in nationwide. Here’s what the rule requires, when changes take effect, and what families should realistically expect in 2026.
Enhanced Affordable Care Act premium tax credits ended December 31, 2025. Here’s how 2026 Marketplace coverage works under the standard subsidy formula, who is most affected, what protections remain, and what families can do now.
Federal agencies extended pandemic-era telehealth flexibilities for prescribing certain controlled substances, including ADHD stimulants, through December 31, 2025. Here’s what that meant, where things stand in March 2026, and how patients can avoid treatment disruptions.
Clear, evidence-based health reporting is more than a writing style—it’s a public health tool. Here’s how federal health literacy guidance and research on medical evidence explain why plain-language communication protects patients and communities.
End of content
End of content
